Analyst Ratings for Aclaris Therapeutis (ACRS)
ACRS Rating Summary
ACRS Price Target Summary
- Highest: $16.00 (H.C. Wainwright)
- Lowest: $3.00 (Stifel)
- Average: $8.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.40 (+174.5%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 85%
Avg. $ Target:
$8.40 (+174.5%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/30/2026 | Craig-Hallum | Adam Vogel | New Coverage | Buy (N/A) |
10.00 (N/A) |
3.43 (3.06) |
-10.79% | Details |
| 7/10/2025 | Piper Sandler | Biren Amin | New Coverage | Overweight (N/A) |
6.00 (N/A) |
1.45 (3.06) |
111.03% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
